MycoRx LLC

MOUNT PLEASANT, SC · CIK 0002133992 · Biotech · Private

Antifungal drug candidates to treat drug-resistant fungal infections

mycorx.org →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$600K
1 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$600,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1880TBC II LLC—$3.5M
1881Cardiol Therapeutics Inc.—$6.0M
1882IMMUNO NANO MED, INC——
1883MycoRx LLC—$600K
1884Biosplice Therapeutics——
1885Krystal Biotech, Inc.—$11M
1886SANOSTEM GLOBAL, LLC—$3.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Abhiram MaddiExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.